Effects of trimethyltin on hippocampal dopaminergic markers and cognitive behaviour

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 4, 2012, Pages 1107-1119

  Mignini, F ^a   Nasuti, C ^a   Artico, M ^b   Giovannetti, F ^b   Fumagalli, L ^b   Iannetti, G ^b   Pompili, E ^b   Fabrizi, Cinzia ^b  

^a UNIVERSITY OF CAMERINO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Dopamine; Hippocampus; Rat; Spatial reference memory; Trimethyltin; VMAT

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; TRIMETHYLTIN; VESICULAR MONOAMINE TRANSPORTER 1; VESICULAR MONOAMINE TRANSPORTER 2; BIOLOGICAL MARKER; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; COGNITION; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REFERENCE MEMORY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPATIAL LEARNING; ANIMAL CELL; BRAIN REGION; DOPAMINERGIC SYSTEM; DRUG EFFECT; ENVIRONMENT; LOCOMOTION; MEMORY CONSOLIDATION; MORRIS WATER MAZE TEST; NERVE CELL; PROTEIN FUNCTION; REARING; SPATIAL MEMORY; TASK PERFORMANCE;

EID: 84872921791     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500428     Document Type: Article

References (31)

1. Mignini F, Streccioni V, Amenta F. Autonomic innervation of immune organs and neuroimmune modulation. Auton Autacoid Pharmacol 2003; 23:1-25. (Pubitemid 36917752)
2. Meredith EJ, Chamba A, Holder MJ, Barnes MN, Gordon J. Close encounters of the monoamine kind: immune cells betray their nervous disposition. Immunology 2005; 115:289-95. (Pubitemid 40896027)
3. Giros B, Caron MG. Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 1993; 14:43-9. (Pubitemid 23049339)
4. Mignini F, Tomassoni D, Traini E, Amenta F. Dopamine, vesicular transporters and dopamine receptor expression and localization in rat thymus and spleen. J Neuroimmunol 2009; 206:5-13.
5. Mignini F, Sabbatini M, D'Andrea V, Cavallotti C. Intrinsic innervation and dopaminergic markers after experimental denervation in rat thymus. Eur J Histochem 2010; 54:e17.
6. Cavallotti C, Mancone M, Bruzzone P, Sabbatini M, Mignini F. Dopamine receptor subtypes in the native human heart. Heart Vessels 2010; 25:432-7.
7. Pompili E, Fabrizi C, Nori SL, Panetta B, Geloso MC, Corvino V, Michetti F, Fumagalli L. Protease-activated receptor-1 expression in rat microglia after trimethyltin treatment. J Histochem Cytochem 2011; 59:302-11.
8. Geloso MC, Corvino V, Michetti F. Trimethyltin-induced hippocampal degeneration as a tool to investigate neurodegenerative processes. Neurochem Int 2011; 58:729-38
9. Hanin I, Krigman MR, Mailman RB. Central neurotransmitter effects of organotin compounds: trials, tribulations and observations. Neurotoxicology 1984; 5:267-77.
10. Balaban CD, O'Callaghan JP, Billinsley ML. Trimethyltin-induced neuronal damage in the rat brain: comparative studies using silver degeneration stains, immunocytochemistry and immunoassay for neuronotypic and gliotypic proteins. Neuroscience 1988; 26:337-61.
11. Kruger K, Diepgrond V, Ahnefeld M, Wackerbeck C, Madeja M, Binding N, Musshoff U. Blockade of glutamatergic and GABAergic receptor channels by trimethyltin chloride. Br J Pharmacol 2005; 144:283-92. (Pubitemid 40216126)
12. Selcher JC, Xu W, Hanson JE, Malenka RC, Madison DV. Glutamate receptor subunit GluA1 is necessary for long-term potentiation and synapse unsilencing, but not long-term depression in mouse hippocampus. Brain Res 2012; 1435:8-15.
13. Lee KW, Kim HC, Lee SY, Jang CG. Methamphetamine-sensitized mice are accompanied by memory impairment and reduction of N-methyl-d-aspartate receptor ligand binding in the prefrontal cortex and hippocampus. Neuroscience 2011; 31:101-107.
14. O'Carroll CMO, Martin SJ, Sandin J, Frenguelli B, Morris RGM. Dopaminergic modulation of the persistence of one-trial hippocampus-dependent memory. Learn Mem 2006; 13:760-69. (Pubitemid 44871677)
15. Lisman JE, Grace AA. The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron 2005; 46:703-13. (Pubitemid 40733126)
16. Paxinos G, Watson C. The Rat Brain in Sterotaxic Coordinates. 6th Ed. San Diego: Academic Press. 2007
17. Gallagher M, Burwell R, Burchinal M. Severity of spatial learning impairment in aging: development of a learning index for performance in the Morris water maze. Behav Neurosci 1993; 107:618-26. (Pubitemid 23259627)
18. Nasuti C, Falcioni ML, Nwankwo IE, Cantalamessa F, Gabbianelli R. Effect of permethrin plus antioxidants on locomotor activity and striatum in adolescent rats. Toxicology 2008; 251:45-50.
19. Levay EA, Govic A, Penman J, Paolini AG, Kent S. Effects of adult onset calorie restriction on anxiety-like behavior in rats. Physiol Behav 2007; 5:889-96. (Pubitemid 350101680)
20. Earley B, Burke M, Leonard BE. Behavioural, biochemical and histological effects of trimethyltin (TMT) induced brain damage in the rat. Neurochem Int 1992; 21:351-66.
21. Ortiz O, Delgado-García JM, Espadas I, Bahí A, Trullas R, Dreyer JL, Gruart A, Moratalla R. Associative learning and CA3-CA1 synaptic plasticity are impaired in D1R null, Drd1a-/- mice and in hippocampal siRNA silenced Drd1a mice. J Neurosci 2010; 30:12288-300.
22. Batchelor M, Schenk JO. Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J Neurosci 1998; 15:10304-9.
23. Meiergerd SM, Patterson TA, Schenk JO. D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J Neurochem 1993; 61:764-7.
24. Dickinson SD, Sabeti J, Larson GA, et al. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J Neurochem 1993; 72:148-56.
25. Bolan EA, Kivell B, Jaligam V, et al. D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol Pharmacol 2007; 71:1222-32. (Pubitemid 46661542)
26. El-Ghundi M, Fletcher PJ, Drago J, Sibley DR, O'Dowd BF, George SR. Spatial learning deficit in dopamine D(1) receptor knockout mice. Eur J Pharmacol 1999; 27:95-106.
27. Huang YY, Kandel ER. D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus. Proc Natl Acad Sci USA 1995; 92:2446-50.
28. Xia XG, Schmidt N, Teismann P, Ferger B, Schulz JB. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation. J Neurochem 2001; 79:63-70. (Pubitemid 32946643)
29. Schuldiner S, Shirvan A, Linial M. Vesicular neurotransmitter transporters: from bacteria to humans. Physiol Rev 1995; 75:369-392.
30. Volz TJ, Hanson GR, Fleckenstein AE. Kinetic analysis of developmental changes in vesicular monoamine transporter-2 function. Synapse 2006; 60:474-7. (Pubitemid 44380159)
31. Fei H, Grygoruk A, Brooks ES, Chen A, Krantz DE. Trafficking of vesicular neurotransmitter transporters. Traffic 2008; 9:1425-36.